Substance Abuse and Mental Health Services Administration

Substance Abuse and Mental Health Services Administration is presented in Dopesick through two forms of evidence: national statistics on substance use and federal guidance relevant to pregnant patients with opioid use disorders. These citations help frame the scale of the crisis and the medical stakes of treatment, even as the book’s local accounts show how far evidence and guidance can be from care that patients can actually obtain.

Data and the Scale of Substance Use

The book cites results from the 2015 National Survey on Drug Use and Health, available through Substance Abuse and Mental Health Services Administration’s data site. The figures distinguish among different forms of substance-use disorder: of 20.5 million Americans with a substance use disorder, 2 million had prescription opioid-use disorder and 591,000 were addicted to heroin. The distinctions matter in a narrative tracing movement between prescription opioids and heroin; they keep the national picture from collapsing unlike forms of dependence into one statistic.

The survey functions as a measure of the wider problem rather than as an account of any one community. Dopesick sets national estimates alongside scenes of opioid-related emergencies and the uneven availability of treatment in Virginia, connecting population-level evidence to the people navigating local systems without suggesting that the statistics alone explain their individual circumstances.

Guidance on Opioid Use During Pregnancy

A 2016 federal document, A Collaborative Approach to the Treatment of Pregnant Women with Opioid Use Disorders, is cited for the warning that abruptly stopping opioid use during pregnancy can result in premature labor, fetal distress, or miscarriage. In Tess Henry’s story, the stakes of pregnancy and treatment are concrete: after leaving jail while nearly seven months pregnant, she entered the Life Center of Galax, one of the few Virginia facilities described as accepting patients receiving medication-assisted treatment. She took Subutex, a buprenorphine formulation then recommended for some pregnant patients.

The guidance establishes an important distinction in the book’s treatment discussions: stopping opioid use is not, by itself, a risk-free medical intervention during pregnancy. Tess’s account also shows that treatment involved clinical and practical choices, including medication and the difficulty of finding a facility willing to accept her. The cited guidance supplies medical context; the narrative does not portray Substance Abuse and Mental Health Services Administration as arranging Tess’s admission or overseeing her care.

Evidence and the Treatment Gap

Substance Abuse and Mental Health Services Administration’s cited data and pregnancy guidance sit within a book-length account of the distance between evidence and access. Tess’s buprenorphine medication was largely covered by insurance, but addiction-doctor visits required substantial cash payments, and appointments could be frequent. The account describes waiting lists and the difficulty of finding affordable treatment, pressures that shaped whether evidence-based care was practically available.

At the community level, Roanoke’s Hope Initiative assembled a spreadsheet listing thirty-six rehabilitation and aftercare providers, matching possible referrals to patients’ finances and bed availability. Volunteers differed over medication-assisted treatment, with some opposing the use of medication despite scientific evidence. These local efforts illustrate the varied and sometimes contested treatment landscape in which federal guidance and national data acquire significance; they are not described as programs run by Substance Abuse and Mental Health Services Administration.

Role in the Book

The agency’s role in Dopesick is documentary and contextual. Its cited materials contribute a national measure of opioid-related disorder and a medical warning relevant to pregnancy, while the narrative’s central service-access stories follow families, clinicians, volunteers, and local institutions. Keeping those roles distinct clarifies the book’s larger point: the existence of data and clinical guidance does not ensure that patients can reach timely, affordable, sustained treatment.